NAUT News and Press, Nautilus Biotechnology Inc. From 09/28/23

2023-09-28 17:12:16 ET Gainers: Editas Medicine ( NASDAQ: EDIT ) +8% . Marqeta ( MQ ) +3% . Cipher Mining ( CIFR ) +3% . Aclaris Therapeutics ( ACRS ) +2% . Biora Therapeutics ( BIOR ) +2% . Losers: Jaguar Global Grow...

SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences: Morgan Stanley 2...

SEATTLE, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences: Canaccord 43 rd...

2023-08-02 13:33:02 ET Nautilus Biotechnology, Inc. (NAUT) Q2 2023 Earnings Conference Call August 02, 2023 08:30 AM ET Company Participants Carrie Mendivil - Investor Relations Sujal Patel - Co-Founder, Chief Executive Officer, President, Secretary & Director ...

2023-08-02 07:49:27 ET Nautilus Biotechnology press release ( NASDAQ: NAUT ): Q2 GAAP EPS of -$0.13 beats by $0.01 . Cash, cash equivalents, and investments were $286.7 million as of June 30, 2023. For further details see: Nautilus Biotechnology GAAP EPS...

SEATTLE, Wash., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2023. “I’m e...

2023-08-01 13:25:46 ET Nautilus Biotechnology ( NASDAQ: NAUT ) is scheduled to announce Q2 earnings results on Tuesday, August 2nd, before market open. The consensus EPS Estimate is -$0.16 (-33.3% Y/Y) and the consensus Revenue Estimate is $0M Over the last 3 months, E...

SEATTLE, July 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the second quarter before market open on Wednesday, August 2,...

SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences: Jefferies 2023 Hea...

2023-05-02 14:57:06 ET Nautilus Biotechnology, Inc. (NAUT) Q1 2023 Earnings Conference Call May 2, 2023 08:30 ET Company Participants Carrie Mendivil - Investor Relations Sujal Patel - Co-Founder, Chief Executive Officer, President, Secretary & Director Anna ...